NCT03441230

Brief Summary

There is a clear need for a novel method that can readily assess gastric motility in daily clinical practice. Isometric determination of the stomach motility would avoid the use of a large flaccid balloon while still being affordable. The aim of this study was to determine the optimal balloon characteristics that enable to measure motility-induced pressure changes in healthy volunteers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2017

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

February 2, 2018

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 22, 2018

Completed
Last Updated

February 22, 2018

Status Verified

February 1, 2018

Enrollment Period

11 months

First QC Date

February 2, 2018

Last Update Submit

February 20, 2018

Conditions

Keywords

stomachmotility

Outcome Measures

Primary Outcomes (1)

  • Detection of distal stomach-induced contractions using various intragastric balloons

    A comparison of various intragastric balloons for the assessment of gastric motility

    up to 1 year

Study Arms (10)

Circumference of 13 cm, sphere form (diameter of 4 cm)

ACTIVE COMPARATOR
Device: Balloon characteristics

Circumference of 13 cm, cylinder form, length 11 cm

ACTIVE COMPARATOR
Device: Balloon characteristics

Circumference of 16 cm, sphere form (diameter of 5 cm)

ACTIVE COMPARATOR
Device: Balloon characteristics

Circumference of 16 cm, cylinder form, length 11 cm

ACTIVE COMPARATOR
Device: Balloon characteristics

Circumference of 16 cm, cylinder form, length 18 cm

ACTIVE COMPARATOR
Device: Balloon characteristics

Circumference of 19 cm, sphere form (diameter of 6 cm)

ACTIVE COMPARATOR
Device: Balloon characteristics

Circumference of 19 cm, cylinder form, length 11 cm

ACTIVE COMPARATOR
Device: Balloon characteristics

Circumference of 22 cm, sphere form (diameter of 7 cm)

ACTIVE COMPARATOR
Device: Balloon characteristics

Circumference of 25 cm, sphere form (diameter of 8 cm)

ACTIVE COMPARATOR
Device: Balloon characteristics

Circumference of 28 cm, sphere form (diameter of 9 cm)

ACTIVE COMPARATOR
Device: Balloon characteristics

Interventions

Different size balloon

Circumference of 13 cm, cylinder form, length 11 cmCircumference of 13 cm, sphere form (diameter of 4 cm)Circumference of 16 cm, cylinder form, length 11 cmCircumference of 16 cm, cylinder form, length 18 cmCircumference of 16 cm, sphere form (diameter of 5 cm)Circumference of 19 cm, cylinder form, length 11 cmCircumference of 19 cm, sphere form (diameter of 6 cm)Circumference of 22 cm, sphere form (diameter of 7 cm)Circumference of 25 cm, sphere form (diameter of 8 cm)Circumference of 28 cm, sphere form (diameter of 9 cm)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • They are between 18-60 years old.
  • Male and female.
  • Patients must provide witnessed written informed consent prior to any study procedures being performed.

You may not qualify if:

  • They are older than 60 years old and younger than 18 years.
  • They are taking medication.
  • Have severely decreased kidney function.
  • Have severely decreased liver function.
  • Have severe heart disease, for example a history of irregular heartbeats, angina or heart attack.
  • Have severe lung disease.
  • Have severe psychiatric illness or neurological illness.
  • Have any gastrointestinal disease.
  • Have any dyspeptic symptoms.
  • Women that are pregnant or breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

Location

MeSH Terms

Conditions

Gastroparesis

Condition Hierarchy (Ancestors)

Stomach DiseasesGastrointestinal DiseasesDigestive System DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

February 2, 2018

First Posted

February 22, 2018

Study Start

February 15, 2016

Primary Completion

January 20, 2017

Study Completion

January 20, 2017

Last Updated

February 22, 2018

Record last verified: 2018-02

Data Sharing

IPD Sharing
Will not share

Locations